PROMOMED acted as an expert at the Russian-Chinese Pharmaceutical Cooperation Forum

PROMOMED, a leading Russian biopharmaceutical company, participated as an expert in the Second Russian-Chinese Pharmaceutical Cooperation Forum. The event, which took place in Shanghai, was aimed at strengthening the comprehensive strategic partnership between Russia and China in the development, registration and mutual exchange of medicines.

Within the framework of the forum, Kira Zaslavskaya, Director of New Products at PROMOMED, made a presentation in which she shared her positive experience in developing Russian-Chinese research and scientific production activities to accelerate innovation in medical practice.

"The high demand for biopharmaceutical innovations for the treatment of common and socially significant diseases indicates the need to accelerate the creation of new drugs at all stages: from screening ideas to conducting clinical trials. The development of international cooperation between Russian and Chinese innovative companies, combining extensive experience, scientific data, technological capabilities, and joint medical research will certainly ensure the required acceleration and implementation of breakthrough solutions for healthcare," said Kira Zaslavskaya.

PROMOMED is engaged in full-scale work to provide the country with modern high-tech medicines in order to achieve national drug independence. The company develops innovative activities, including in the framework of international scientific research, and actively uses its own production potential to provide the country with the medicines in demand.

The invitation to speak at the Russian-Chinese Pharmaceutical Cooperation Forum (with the participation of the Russian Ministry of Industry and Trade, Rospatent and other regulatory authorities and expert organizations) demonstrates the recognition of the expertise of the PROMOMED Group and its active participation in the development of international cooperation to create advanced solutions in healthcare.